Do Patients with Mental Illness Undergoing Office-Based Sedation Require an Increased Propofol Dosage?

Jaehee Hong,Reese R. Triana,Md Tareq Ferdous Khan,Anshya Tewari,Brianna Yin,Deepak G. Krishnan

DOI: https://doi.org/10.1016/j.joms.2024.04.001

IF: 1.9

2024-04-07

Journal of Oral and Maxillofacial Surgery

Abstract:Background Providers report needing higher sedative doses to achieve adequate sedation in patients with mental illnesses. These claims however have not been thoroughly assessed. Purpose The study purpose was to measure the association between mental illness and the propofol dosage necessary to achieve a satisfactory level of anesthesia. Study design, setting, sample The study consisted of a single-center, retrospective cohort consisting of patients treated by oral and maxillofacial surgery at the University of Cincinnati Medical Center in 2020. The study was comprised of subjects 15 or older who were American society of Anesthesiologists classification (ASA) classification I or II. Subjects under 15 or ASA III or higher were excluded from the study. Predictor variable The predictor variable was the presence or absence of mental illness. Main outcome variables The primary outcome was the total dose of propofol, measured as total amount of propofol administered divided by patient's weight in kilograms divided by the length of the procedure in minutes (mg/kg/min). The secondary outcome was the Richmond Agitation-Sedation Scale (RASS) score achieved during sedation. Covariates Sex, race, ethnicity, age, weight, body mass index (BMI), ASA score, prior tobacco use, marijuana use, use of adjunct midazolam, fentanyl, ketamine during procedure, and type of procedure served as covariates. Analyses Test statistics were calculated using Wilcoxon rank-sum test, Kruskal-Wallis test, Spearman rank correlation test, and χ2 test for bivariate analyses. Linear and logistic regression models were used to estimate association while controlling for confounding. P -values ≤ .05 were considered statistically significant. Results The study sample was 409 subjects (36.92% male, mean age 28.27 ± 12.20 years). In bivariate analysis mental illness did not show any association with propofol dose (mean dose with mental illness 150.85 ± 143.97 mg/kg/min, mean dose without mental illness 116.54 ± 104.16, P = 0.08) or RASS score (sufficiently sedated with mental illness 63.38%, sufficiently sedated without mental illness 58.80%, P = 0.36). After adjusting for all previously mentioned covariates, mental illness was statistically associated with propofol dose (P <0.01). Adjusting for covariates only sex had a statistically significant association with RASS score ( P <0.05). Conclusions and Relevance The findings suggest that a patient's mental illness may influence the amount of sedative required to achieve satisfactory anesthesia.

dentistry, oral surgery & medicine